Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-13 of 13 for your search:
Drug:
Ad5CMV-p53 gene
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of Oral and Intramucosal Ad5CMV-p53 Gene in Patients With Diffuse Premalignant Carcinoma of the Oral Cavity or Oral Pharynx
Phase:
Phase II, Phase I
Type:
Prevention
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MDA-ID-00193
, NCI-6053, NCT00064103, 6053
2.
Phase II Randomized Study of Two Treatment Regimens of Recombinant Adenoviral p53 Gene (Ad5CMV-p53 gene) Administered by Intratumoral Injections in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 07/1999)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
RP-T-201
, SCCC-97050, NCI-V98-1393
3.
Phase II Study of Ad5CMV-p53 in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 04/2000)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AVENTIS-T-202
, MCC-11653, RP-T-202, NCI-V98-1394, NCT00003257
4.
Phase II Study of Surgery and Ad5CMV-p53 Gene Followed By Cisplatin and Radiotherapy in Patients With Newly Diagnosed Resectable Stage III or IV Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx, or Larynx
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0011
, S0011, NCT00017173
5.
Phase II Study of Docetaxel, Doxorubicin, and Ad5CMV-p53 Gene Therapy (INGN 201) in Patients With Locally Advanced Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
INTROGEN-201-010
, MDA-ID-00008, NCT00044993
6.
Phase I Study of Percutaneous Injections of Adenovirus P53 Construct (Adeno-P53) for Hepatocellular Carcinoma (Summary Last Modified 05/2000)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
PCI-96-035
, NCI-T96-0059, NCT00003147, T96-0059
7.
Phase I Study of Adenovirus p53 in Patients With Locally Advanced or Metastatic Bladder Cancer (Summary Last Modified 06/2002)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MDA-DM-96172
, NCI-T96-0073, NCT00003167, T96-0073
8.
Phase I Study of Intralesional Gene Therapy Plus Chemotherapy in Patients With Breast Cancer (Summary Last Modified 06/2001)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
FCCC-97009
, NCI-T97-0042, NCT00004038, T97-0042
9.
Phase I Study of Intraperitoneal Adenoviral p53 Gene Therapy in Patients With Advanced Recurrent or Persistent Ovarian Cancer (Summary Last Modified 06/2002)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UTSMC-089733300
, NCI-T97-0096, NCT00003450, T97-0096
10.
Phase I Study of Adenovirus p53 in Patients with Platinum- and Paclitaxel-Resistant Ovarian Epithelial Cancer (Summary Last Modified 06/2002)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MDA-ID-97228
, NCI-T97-0111, NCT00003588, T97-0111
11.
Phase I Pilot Study of Adenovirus p53 Administered by Bronchoalveolar Lavage in Patients With Bronchoalveolar Cell Lung Carcinoma
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
E-6597
, NCT00003649, E6597
12.
Phase I Study of Adenovirus p53 Gene Therapy in Patients with Recurrent Malignant Gliomas (Summary Last Modified 04/2002)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NABTC-9703
, NCT00004041
13.
Phase I Pilot Study of Adenovirus p53 Gene Therapy and Radiotherapy in Patients With Non-Small Cell Lung Cancer
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ECOG-8597
, E8597, NCT00004225
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute